OpGen

OpGen Interest Expense

The Interest Expense of OpGen (OPGN) as of Oct 19, 2026 is 364,500.00 USD. In the previous year, Interest Expense was -1.92 M USD — a change of -118.99% (higher).

Interest Expense

364,500.00USD

YoY

-118.99%

Last updated:

Interest Expense of OpGen is 2024 364,500.00 USD. Interest Expense of OpGen was 2023 -1.92 M USD. It decreases by -118.99% higher compared to the previous year.

The OpGen Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-153,500.00 USD
Jan 1, 2018
-187,900.00 USD
Jan 1, 2019
-260,100.00 USD
Jan 1, 2020
-4.24 M USD
Jan 1, 2021
-3.99 M USD
Jan 1, 2022
-2.72 M USD
Jan 1, 2023
-1.92 M USD
Jan 1, 2024
364,500.00 USD
The OpGen Interest Expense history
YEARInterest ExpenseYoY
364,500.00USD-118.99%
-1.92 MUSD-29.31%
-2.72 MUSD-31.97%
-3.99 MUSD-5.94%
-4.24 MUSD+1,532.03%
-260,100.00USD+38.42%
-187,900.00USD+22.41%
-153,500.00USD-2.48%
-157,400.00USD-93.50%
-2.42 MUSD+2,078.06%
-111,200.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Interest Expense of OpGen is 364,500.00 USD in 2024.

Interest Expense of OpGen changed from -1.92 M USD to 364,500.00 USD, representing a -118.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense OpGen since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's OpGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — OpGen

All Key Metrics — OpGen